Not yet recruitingPhase 3NCT06855108

Caffeine for Hypoxic Ischemic Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NICHD Global Network for Women's and Children's Health
Principal Investigator
Melissa Bauserman, MD, MPH, MSN, DNP, FNP-C
University of North Carolina, Chapel Hill
Intervention
Caffeine citrate oral solution(drug)
Enrollment
830 target
Eligibility
All sexes
Timeline
20252030

Study locations (7)

Collaborators

RTI International · University of North Carolina, Chapel Hill · Kinshasa School of Public Health · Institute of Nutrition of Central America and Panama (INCAP) · Lata Medical Research Foundation, Nagpur · Aga Khan University · University Teaching Hospital, Lusaka, Zambia · KLE Academy of Higher Education and Research (Deemed- to- be-University), Jawaharlal Nehru Medical College (JNMC), Belagavi, India · Bill and Melinda Gates Foundation · University of Virginia · University of Alabama at Birmingham · Thomas Jefferson University · Columbia University · University of Colorado, Denver · International Centre for Diarrhoeal Disease Research, Bangladesh

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06855108 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials